When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

Medtronic Executives to Speak at Upcoming Investor Conferences

DUBLIN, May 25, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor conferences:

Jefferies Virtual Healthcare Conference
Wednesday, June 2, 2021, at 1:30 pm EDT
Sean Salmon, executive vice president & president, cardiovascular portfolio and president, diabetes operating unit, will answer questions about the company.

Bernstein 37th Annual Strategic Decisions Conference
Thursday, June 3, 2021, at 3:30 pm EDT
Geoff Martha, chairman & chief executive officer, will make a presentation and answer questions about the company.

Goldman Sachs 42nd Annual Health Care Conference
Tuesday, June 8, 2021, at 8:00 am EDT
Geoff Martha, chairman & chief executive officer, will answer questions about the company.

A live webcast for each session will be available on the date and time of each of the conferences noted above by clicking on the Investors Events link at http://investorrelations.medtronic.com. An archived audio file will be available for replay on the same webpage later in the day.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. 

Contacts:




Erika Winkels      

Ryan Weispfenning

Public Relations   

Investor Relations

+1-763-526-8478  

+1-763-505-4626

SOURCE Medtronic plc

Related Links

http://www.medtronic.com

Modal title

Also from this source

Medtronic Evolut™ TAVR System Shows Strong Performance at Two...


Late Breaking Data at EuroPCR Demonstrates Long-Term Benefits of...

Explore

More news releases in similar topics

Contact Cision

Products

About

Cision Distribution Helpline
888-776-0942
Copyright © 2021 Cision US Inc.